-
Advance of the Year: Immunotherapy 2.0 - -
| Artigo | Autor(es) | Referência |
|---|---|---|
| Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. | Ribas Antoni, Hamid Omid, Daud Adil, Hodi F Stephen, Wolchok Jedd D, Kefford Richard, Joshua Anthony M, Patnaik Amita, Hwu Wen-Jen, Weber Jeffrey S, Gangadhar Tara C, Hersey Peter, Dronca Roxana, Joseph Richard W, Zarour Hassane, Chmielowski Bartosz, Lawrence Donald P, Algazi Alain, Rizvi Naiyer A, Hoffner Brianna, Mateus Christine, Gergich Kevin, Lindia Jill A, Giannotti Maxine, Li Xiaoyun Nicole, Ebbinghaus Scot, Kang S Peter, Robert Caroline | JAMA. 2016 Apr; 315(Apr):1600-9. doi: 10.1001/jama.2016.4059. pii: . |
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. | Ferlay Jacques, Soerjomataram Isabelle, Dikshit Rajesh, Eser Sultan, Mathers Colin, Rebelo Marise, Parkin Donald Maxwell, Forman David, Bray Freddie | International journal of cancer. 2015 Mar; 136(Mar):E359-86. doi: 10.1002/ijc.29210. pii: . |
| Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | Ferris Robert L, Blumenschein George, Fayette Jerome, Guigay Joel, Colevas A Dimitrios, Licitra Lisa, Harrington Kevin, Kasper Stefan, Vokes Everett E, Even Caroline, Worden Francis, Saba Nabil F, Iglesias Docampo Lara C, Haddad Robert, Rordorf Tamara, Kiyota Naomi, Tahara Makoto, Monga Manish, Lynch Mark, Geese William J, Kopit Justin, Shaw James W, Gillison Maura L | The New England journal of medicine. 2016 11; 375(11):1856-1867. |
| Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial. | Younes Anas, Santoro Armando, Shipp Margaret, Zinzani Pier Luigi, Timmerman John M, Ansell Stephen, Armand Philippe, Fanale Michelle, Ratanatharathorn Voravit, Kuruvilla John, Cohen Jonathon B, Collins Graham, Savage Kerry J, Trneny Marek, Kato Kazunobu, Farsaci Benedetto, Parker Susan M, Rodig Scott, Roemer Margaretha G M, Ligon Azra H, Engert Andreas | The Lancet. Oncology. 2016 Sep; 17(Sep):1283-94. doi: 10.1016/S1470-2045(16)30167-X. pii: S1470-2045(16)30167-X. |
| PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. | Roemer Margaretha G M, Advani Ranjana H, Ligon Azra H, Natkunam Yasodha, Redd Robert A, Homer Heather, Connelly Courtney F, Sun Heather H, Daadi Sarah E, Freeman Gordon J, Armand Philippe, Chapuy Bjoern, de Jong Daphne, Hoppe Richard T, Neuberg Donna S, Rodig Scott J, Shipp Margaret A | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 08; 34(08):2690-7. doi: 10.1200/JCO.2016.66.4482. pii: . |
| Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. | Reck Martin, Rodríguez-Abreu Delvys, Robinson Andrew G, Hui Rina, Csőszi Tibor, Fülöp Andrea, Gottfried Maya, Peled Nir, Tafreshi Ali, Cuffe Sinead, O'Brien Mary, Rao Suman, Hotta Katsuyuki, Leiby Melanie A, Lubiniecki Gregory M, Shentu Yue, Rangwala Reshma, Brahmer Julie R, | The New England journal of medicine. 2016 11; 375(11):1823-1833. |
| Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. | Herbst Roy S, Baas Paul, Kim Dong-Wan, Felip Enriqueta, Pérez-Gracia José L, Han Ji-Youn, Molina Julian, Kim Joo-Hang, Arvis Catherine Dubos, Ahn Myung-Ju, Majem Margarita, Fidler Mary J, de Castro Gilberto, Garrido Marcelo, Lubiniecki Gregory M, Shentu Yue, Im Ellie, Dolled-Filhart Marisa, Garon Edward B | Lancet (London, England). 2016 Apr; 387(Apr):1540-1550. doi: 10.1016/S0140-6736(15)01281-7. pii: S0140-6736(15)01281-7. |
| Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma. | Schadendorf Dirk, Hodi F Stephen, Robert Caroline, Weber Jeffrey S, Margolin Kim, Hamid Omid, Patt Debra, Chen Tai-Tsang, Berman David M, Wolchok Jedd D | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Jun; 33(Jun):1889-94. doi: 10.1200/JCO.2014.56.2736. pii: . |
| Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure. | Armand Philippe, Shipp Margaret A, Ribrag Vincent, Michot Jean-Marie, Zinzani Pier Luigi, Kuruvilla John, Snyder Ellen S, Ricart Alejandro D, Balakumaran Arun, Rose Shelonitda, Moskowitz Craig H | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 11; 34(11):3733-3739. doi: 10.1200/JCO.2016.67.3467. pii: . |
| Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy. | Eggermont Alexander M M, Chiarion-Sileni Vanna, Grob Jean-Jacques, Dummer Reinhard, Wolchok Jedd D, Schmidt Henrik, Hamid Omid, Robert Caroline, Ascierto Paolo A, Richards Jon M, Lebbé Céleste, Ferraresi Virginia, Smylie Michael, Weber Jeffrey S, Maio Michele, Bastholt Lars, Mortier Laurent, Thomas Luc, Tahir Saad, Hauschild Axel, Hassel Jessica C, Hodi F Stephen, Taitt Corina, de Pril Veerle, de Schaetzen Gaetan, Suciu Stefan, Testori Alessandro | The New England journal of medicine. 2016 11; 375(11):1845-1855. |
| Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. | Hamanishi Junzo, Mandai Masaki, Ikeda Takafumi, Minami Manabu, Kawaguchi Atsushi, Murayama Toshinori, Kanai Masashi, Mori Yukiko, Matsumoto Shigemi, Chikuma Shunsuke, Matsumura Noriomi, Abiko Kaoru, Baba Tsukasa, Yamaguchi Ken, Ueda Akihiko, Hosoe Yuko, Morita Satoshi, Yokode Masayuki, Shimizu Akira, Honjo Tasuku, Konishi Ikuo | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Dec; 33(Dec):4015-22. doi: 10.1200/JCO.2015.62.3397. pii: . |
| Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. | Topalian Suzanne L, Sznol Mario, McDermott David F, Kluger Harriet M, Carvajal Richard D, Sharfman William H, Brahmer Julie R, Lawrence Donald P, Atkins Michael B, Powderly John D, Leming Philip D, Lipson Evan J, Puzanov Igor, Smith David C, Taube Janis M, Wigginton Jon M, Kollia Georgia D, Gupta Ashok, Pardoll Drew M, Sosman Jeffrey A, Hodi F Stephen | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Apr; 32(Apr):1020-30. doi: 10.1200/JCO.2013.53.0105. pii: . |